ESMC — Escalon Medical Balance Sheet
0.000.00%
- $1.30m
- -$1.26m
- $12.05m
Annual balance sheet for Escalon Medical, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.594 | 0.89 | 0.209 | 0.546 | 3.07 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.54 | 1.65 | 2.12 | 1.5 | 1.9 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 4.19 | 4.64 | 4.4 | 4.61 | 7.01 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.841 | 0.538 | 0.249 | 0.289 | 0.854 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 5.17 | 5.31 | 4.76 | 4.99 | 9.13 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3 | 2.85 | 2.67 | 2.69 | 2.39 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 3.69 | 3.37 | 2.95 | 3.08 | 3.2 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 1.48 | 1.93 | 1.81 | 1.92 | 5.93 |
| Total Liabilities & Shareholders' Equity | 5.17 | 5.31 | 4.76 | 4.99 | 9.13 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |